- Home
- RMT vs SAGE Comparison
RMT vs SAGE Comparison
Compare RMT & SAGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RMT
- SAGE
- Stock Information
- Founded
- RMT 1993
- SAGE 2010
- Country
- RMT United States
- SAGE United States
- Employees
- RMT N/A
- SAGE N/A
- Industry
- RMT Investment Managers
- SAGE Biotechnology: Pharmaceutical Preparations
- Sector
- RMT Finance
- SAGE Health Care
- Exchange
- RMT Nasdaq
- SAGE Nasdaq
- Market Cap
- RMT 467.3M
- SAGE 462.2M
- IPO Year
- RMT N/A
- SAGE 2014
- Fundamental
- Price
- RMT $9.88
- SAGE $5.27
- Analyst Decision
- RMT
- SAGE Hold
- Analyst Count
- RMT 0
- SAGE 19
- Target Price
- RMT N/A
- SAGE $11.53
- AVG Volume (30 Days)
- RMT 111.5K
- SAGE 944.7K
- Earning Date
- RMT 01-01-0001
- SAGE 10-29-2024
- Dividend Yield
- RMT 7.37%
- SAGE N/A
- EPS Growth
- RMT N/A
- SAGE N/A
- EPS
- RMT 1.49
- SAGE N/A
- Revenue
- RMT N/A
- SAGE $106,399,000.00
- Revenue This Year
- RMT N/A
- SAGE N/A
- Revenue Next Year
- RMT N/A
- SAGE $122.78
- P/E Ratio
- RMT $6.18
- SAGE N/A
- Revenue Growth
- RMT N/A
- SAGE 837.60
- 52 Week Low
- RMT $7.67
- SAGE $4.62
- 52 Week High
- RMT $9.51
- SAGE $28.26
- Technical
- Relative Strength Index (RSI)
- RMT 47.44
- SAGE 40.43
- Support Level
- RMT $9.85
- SAGE $5.03
- Resistance Level
- RMT $10.36
- SAGE $5.91
- Average True Range (ATR)
- RMT 0.12
- SAGE 0.33
- MACD
- RMT -0.06
- SAGE 0.03
- Stochastic Oscillator
- RMT 25.86
- SAGE 27.27
About RMT Royce Micro-Cap Trust Inc.
Royce Micro-Cap Trust Inc is a diversified closed-end investment company. The company is engaged in investing in micro-cap securities. It invests in the consumer discretionary sector including auto components, automobiles, diversified consumer services, hotels, restaurants and leisure, household durables, internet and catalog retail, leisure products, media, multiline retail, textiles, apparels, and luxury goods, Consumer staples sector including beverages, food, and staples retailing, food products, and personal products, Energy sector including energy equipment and services, and oil, gas, and consumable fuels. The company also invests in other sectors including healthcare, financials, industrials, IT, telecommunications, and materials.
About SAGE Sage Therapeutics Inc.
Sage Therapeutics Inc is a clinical-stage biopharmaceutical company focused on brain health medicines. The company is targeting diseases and disorders of the brain with three key focus areas: depression, neurology and neuropsychiatry; also targeting two critical central nervous system, or CNS, receptor systems, GABA and NMDA. Its products ZURZUVAE is a medicine for the treatment of postpartum depression, or PPD, in adults, and ZULRESSO is a CIV injection for the treatment of postpartum depression in individuals 15 years old and older. It also has other drugs in its pipeline such as SAGE-324, Dalzanemdor (SAGE-718) among others.